Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study (Q35914597)

11 August 2017

Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study (English)

1 reference

11 August 2017

0 references

Jeffrey D Lebensburger

1

1 reference

11 August 2017

Scott T Miller

2

1 reference

11 August 2017

Thomas H Howard

3

1 reference

11 August 2017

James F Casella

4

1 reference

11 August 2017

R Clark Brown

5

1 reference

11 August 2017

Ming Lu

6

1 reference

11 August 2017

Rathi V Iyer

7

1 reference

11 August 2017

Sharada Sarnaik

8

1 reference

11 August 2017

Zora R Rogers

9

1 reference

11 August 2017

Winfred C Wang

10

1 reference

11 August 2017

BABY HUG Investigators

11

1 reference

11 August 2017

20 December 2011

1 reference

11 August 2017

Pediatric Blood Cancer

1 reference

11 August 2017

59

1 reference

11 August 2017

4

1 reference

11 August 2017

675-678

1 reference

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

NIH consensus development statement on hydroxyurea treatment for sickle cell disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

The kidney, hepatobiliary system, and spleen in sickle cell anemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

Stroke in a cohort of patients with homozygous sickle cell disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3337342

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

27 July 2018

1 reference

MRI abnormalities of the brain in one-year-old children with sickle cell anemia

21 January 2018

1 reference

Abnormalities of the central nervous system in very young children with sickle cell anemia.

21 January 2018

1 reference

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

21 January 2018

1 reference

Prediction of adverse outcomes in children with sickle cell disease

21 January 2018

1 reference

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes

21 January 2018

1 reference

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

21 January 2018

1 reference

Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London

21 January 2018

1 reference

Newborn experience in the Cooperative Study of Sickle Cell Disease

21 January 2018

1 reference

12 December 2020

Pain in sickle cell disease. Rates and risk factors

1 reference

12 December 2020

The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease

1 reference

12 December 2020

Cerebrovascular accidents in sickle cell disease: rates and risk factors

1 reference

12 December 2020

Identifiers

DOI

10.1002/PBC.24037

1 reference

11 August 2017

1 reference

11 August 2017

1 reference